Comments
Loading...

Pieris Pharmaceuticals

PIRSNASDAQ
Logo brought to you by Benzinga Data
$17.01
-0.3-1.73%
At Close: -
$17.11
0.10.59%
After Hours: 4:47 PM EDT
15 minutes delayed
Palvella Therapeutics, Inc announced it will be merged with Pieris Pharmaceuticals (PIRS) on Wednesday, July 24, 2024

Pieris Pharmaceuticals (NASDAQ:PIRS) Stock Quotes, Forecast and News Summary

Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.

Open$16.53
Close$17.01
Volume / Avg.86.38K / 117.91K
Day Range16.51 - 17.96
52 Wk Range6.20 - 41.78
Market Cap$22.59M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
82
Short Interest
0.97%
Days to Cover1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Pieris Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the disco...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PIRS
VINC

FAQ

Q

How do I buy Pieris Pharmaceuticals (PIRS) stock?

A

You can purchase shares of Pieris Pharmaceuticals (NASDAQ:PIRS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pieris Pharmaceuticals (PIRS) competitors?

Q

What is the target price for Pieris Pharmaceuticals (PIRS) stock?

A

There is no analysis for Pieris Pharmaceuticals.

Q

What is the forecast for Pieris Pharmaceuticals (PIRS) stock?

A

There is no analysis for Pieris Pharmaceuticals to provide a consensus price target.

Q

Current stock price for Pieris Pharmaceuticals (PIRS)?

A

The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $17.11 last updated July 26, 2024 at 4:47 PM EDT.

Q

Does Pieris Pharmaceuticals (PIRS) pay a dividend?

A

There are no upcoming dividends for Pieris Pharmaceuticals.

Q

When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?

A

Pieris Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Q

Is Pieris Pharmaceuticals (PIRS) going to split?

A

There is no upcoming split for Pieris Pharmaceuticals.

Q

What sector and industry does Pieris Pharmaceuticals (PIRS) operate in?

A

Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch